Hannover Rück stock gains as Berenberg lifts price target to 330 euros

Published on 09/18/2026 at 14:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hannover Rück stock trades near EUR 257.00 on September 17, 2026, supported by a fresh Buy rating from Berenberg with a EUR 330.00 price target. Analyst consensus sees an average target of EUR 280.60, while fair-value models point to EUR 247.95 for the reinsurer.

Drohnenaufnahme eines Hurrikans über Küstenstadt mit sichtbarem Auge der Sturmformation — Fotorealistisches Luftbild eines Hurrikans über einer Küstenstadt – ein kraftvolles Motiv für die globale Naturgefahren-Expertise der Hannover Rück SE (ISIN DE0008402215). Die Spiralform des Sturms symbolisiert das Kerngeschäft der Rückversicherung, Illustration mit AI erstellt.

Hannover Rück stock (ISIN DE0008402215) is trading close to the upper end of its recent range, with Xetra data showing a price of 257.00 EUR on September 17, 2026, modestly above the prior close of 255.80 EUR and translating into a daily gain of 0.5 percent for investors watching the reinsurer.

Berenberg’s 330-euro target sets the tone

According to Investing.com on September 17, 2026, Berenberg confirmed its Buy rating on Hannover Rück stock and set a price target of 330.00 EUR, which is roughly 28 percent above the prevailing level around 257.00 EUR and currently the highest target in the analyst field.

The same analyst overview from Investing.com reports that the consensus of 15 analysts implies an average price target of 280.60 EUR as of September 17, 2026, suggesting about 9 percent upside from the current level and underscoring a generally positive, though not euphoric, view on the reinsurer.

Fair-value models flag valuation risk

In the same article, the InvestingPro fair-value model cited by Investing.com estimates a fair value of 247.95 EUR for Hannover Rück stock, which is slightly below the trading level around 257.00 EUR on September 17, 2026 and highlights that not all valuation tools see significant upside from current prices.

According to the same analyst consensus overview from Investing.com, coverage of Hannover Rück comprises 15 analysts with 7 Buy ratings, 7 Hold recommendations and 1 Sell stance as of September 17, 2026, illustrating a split view on the reinsurer’s valuation and sector risks despite the strong Berenberg target.

Recent price level and trading data on Xetra

Per the price snapshot in the Investing.com article dated September 17, 2026, Hannover Rück stock was quoted at 257.00 EUR on Xetra in the afternoon, compared with a prior Xetra close of 255.80 EUR, implying a daily gain of 0.5 percent and marking the fifth consecutive trading day with gains in the European insurance sector environment.

Additional market-data context from a Tradegate-based overview on MarketScreener shows Hannover Rück at 252.30 EUR on Tradegate with a one-day decline of 1.14 percent and a five-day gain of 0.96 percent as of September 18, 2026, underlining that the stock is trading slightly below its recent Xetra peak but still within the upper band of its short-term range.

Analyst support from DZ Bank and others

Beyond Berenberg, Hannover Rück continues to enjoy support from domestic analyst houses. According to finanzen.ch on September 18, 2026, DZ Bank keeps its Buy recommendation for Hannover Rück and continues to see the fair value at 314.00 EUR, adding another bullish voice above the consensus target.

As summarized in a Tradegate quote overview on MarketScreener on September 18, 2026, DZ Bank analyst Thorsten Wenzel reaffirms a positive stance on Hannover Rück with a Buy rating, while the same page indicates an average analyst price objective of 280.60 EUR and a last closing price of 255.20 EUR, reinforcing the picture of moderate expected upside and a broadly supportive analyst environment.

Stock price and investor takeaway

With Hannover Rück stock trading at 257.00 EUR on Xetra as of September 17, 2026, versus an InvestingPro fair-value estimate of 247.95 EUR and an average analyst target of 280.60 EUR, the shares currently sit between quantitative fair-value models and the more optimistic sell-side projections, offering investors a blend of moderate upside potential and valuation discipline.